Stockscreener 앱 받기
0.279
3.12%
-0.009
시간 외 거래:
.27
-0.009
-3.23%
전일 마감가:
$0.288
열려 있는:
$0.29
하루 거래량:
451.39K
Relative Volume:
0.07
시가총액:
$7.94M
수익:
$9.37M
순이익/손실:
$-8.45M
주가수익비율:
-0.3444
EPS:
-0.81
순현금흐름:
$-7.27M
1주 성능:
-8.19%
1개월 성능:
-9.06%
6개월 성능:
-65.51%
1년 성능:
-84.33%
1일 변동 폭
$0.2713
$0.29
1주일 범위
$0.27
$0.31
52주 변동 폭
$0.1639
$2.2592
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
명칭
Bioaffinity Technologies Inc
전화
210-698-5334
주소
3300 NACOGDOCHES ROAD, SAN ANTONIO
BIAF을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
0.279 | 8.20M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
462.39 | 173.97B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
199.76 | 143.61B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
652.11 | 52.65B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
114.13 | 32.56B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
180.09 | 30.58B | 15.50B | 1.33B | 2.16B | 7.34 |
Bioaffinity Technologies Inc 주식(BIAF)의 최신 뉴스
Can bioAffinity Technologies Inc. Equity Warrant maintain its current growth rateLow Price High Return Opportunities - mustnews.co.kr
Published on: 2025-08-08 17:01:07 - beatles.ru
Published on: 2025-08-04 09:31:00 - beatles.ru
What are bioAffinity Technologies Inc. Equity Warrant company’s key revenue driversGet high-impact stock recommendations now - Jammu Links News
How strong is bioAffinity Technologies Inc. Equity Warrant company’s balance sheetMarket-crushing profits - Jammu Links News
What is the dividend policy of bioAffinity Technologies Inc. Equity Warrant stockCapitalize on strategic market trends - Jammu Links News
Is bioAffinity Technologies Inc. Equity Warrant a growth stock or a value stockAchieve rapid wealth accumulation through smart investing - Jammu Links News
bioAffinity Technologies Inc. Stock Analysis and ForecastAchieve rapid financial growth with expert picks - Jammu Links News
Is bioAffinity Technologies Inc. Equity Warrant stock overvalued or undervaluedFree Market Dynamics Reports - Jammu Links News
How volatile is bioAffinity Technologies Inc. stock compared to the marketFree Market Dynamics Reports - Jammu Links News
What analysts say about bioAffinity Technologies Inc. stockFree Predictions - Jammu Links News
What makes bioAffinity Technologies Inc. stock price move sharplyUnlock powerful insights from market experts - Jammu Links News
What catalysts could drive bioAffinity Technologies Inc. Equity Warrant stock higher in 2025Tremendous growth opportunities - Jammu Links News
Published on: 2025-08-03 18:51:54 - Jammu Links News
How does bioAffinity Technologies Inc. Equity Warrant compare to its industry peersBuild a winning investment strategy - Jammu Links News
What are bioAffinity Technologies Inc. company’s key revenue driversPhenomenal capital appreciation - Jammu Links News
Should I hold or sell bioAffinity Technologies Inc. Equity Warrant stock in 2025Achieve breakthrough investment performance - Jammu Links News
Why is bioAffinity Technologies Inc. Equity Warrant stock attracting strong analyst attentionUnprecedented profits - Jammu Links News
What are the latest earnings results for bioAffinity Technologies Inc.Discover the fastest growing stocks today - Jammu Links News
What are the latest earnings results for bioAffinity Technologies Inc. Equity WarrantNavigate market shifts with confidence - Jammu Links News
What is the dividend policy of bioAffinity Technologies Inc. stockLightning-fast growth - Jammu Links News
Is bioAffinity Technologies Inc. Equity Warrant a good long term investmentMarket-crushing profits - Jammu Links News
Why is bioAffinity Technologies Inc. stock attracting strong analyst attentionCapitalize on emerging trends for profits - Jammu Links News
bioAffinity’s CyPath® Lung Test Detects Early Cancer - MSN
Price Consolidation Hints at Upcoming Move in bioAffinity Technologies Inc. Equity WarrantIntraday Trend Analysis for Fast Gains Released - metal.it
bioAffinity Technologies' CyPath Lung Test Detects Early Cancer with High Accuracy - AInvest
What is bioAffinity Technologies Inc. Equity Warrant company’s growth strategySwing Trade Growth Plan With High Returns - Jammu Links News
Annaly Capital to Issue Series J Preferred; Redeemable 2030 | BIAFW SEC FilingForm 8-K - Stock Titan
Building trade automation scripts for bioAffinity Technologies Inc.Optimized Watchlist With Daily Adjustments Launched - metal.it
How Resilient Is bioAffinity Technologies Inc. Stock During Economic DownturnsWeekly Stock Opportunity Radar Scanner Activated - metal.it
Revolutionary CyPath Lung Test Catches Hidden Cancer After Standard Tests Failed: Critical Case Study Reveals - Stock Titan
Published on: 2025-07-28 23:30:16 - metal.it
bioAffinity Technologies Inc. Pullback Analyzed — Is It Time to ExitCommunity Entry Consensus Trade Ideas Shared - metal.it
How many analysts rate bioAffinity Technologies Inc. Equity Warrant as a “Buy”Identify winners with top-tier analysis - Jammu Links News
Technical Models Detect Momentum Build in bioAffinity Technologies Inc. Equity WarrantTarget Return Focused Trade Insights Shared - metal.it
Is bioAffinity Technologies Inc. stock entering bullish territory Free Smart Trend Trading with Weekly Signals - metal.it
What institutional investors are buying bioAffinity Technologies Inc. Equity Warrant stockHigh-profit trading signals - jammulinksnews.com
Is bioAffinity Technologies Inc. a growth stock or a value stockInvest confidently with professional market insights - Jammu Links News
What is the risk reward ratio of investing in bioAffinity Technologies Inc. stockCapitalize on market trends before they peak - Jammu Links News
What is bioAffinity Technologies Inc. company’s growth strategyInvest confidently with real-time data analysis - Jammu Links News
Is it the right time to buy bioAffinity Technologies Inc. Equity Warrant stockTurn market volatility into profit opportunities - Jammu Links News
What catalysts could drive bioAffinity Technologies Inc. stock higher in 2025Invest smarter with expert stock recommendations - Jammu Links News
What is the risk reward ratio of investing in bioAffinity Technologies Inc. Equity Warrant stockFree Trading Psychology Coaching - jammulinksnews.com
Published on: 2025-07-28 05:02:09 - jammulinksnews.com
What are the technical indicators suggesting about bioAffinity Technologies Inc. Equity WarrantUncover the best stocks for explosive growth - Jammu Links News
Bioaffinity Technologies Inc (BIAF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.68%
0.79%
자본화:
|
볼륨(24시간):